Apr 20, 2021SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT Therapeutics
Mar 1, 20214BIO Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round
Jan 25, 20214BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery
